« Fabry Patients Denied March-In Now Sue Under Bayh-Dole | Main | Tolerx - GSK Diabetes Drug Goes Down in Phase III »
As reported in Xconomy, Dendreon has received FDA approval for its new factory in NJ to produce Provenge, its prostate cancer treatment. The new site will allow Dendreon to quadruple its current capacity. With the new production levels, Dendreon has forecasted its sales for Provenge in 2011 in the range of $350-$400 million.
Posted by Bruce Lehr March 11th 2011.
| | |
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b014e86a57681970d
Listed below are links to weblogs that reference Dendreon NJ Factory a "Go" with FDA:
The comments to this entry are closed.
Comments